
Charles River Laboratories International, Inc.· CRL
- Price
- $288.50
- Day
- -1.65%
- Mkt Cap
- $13.90B
- 52W Range
- $144.26 – $303.31
- Volume
- 735.6K
- Beta
- 1.41

Find a company by name or ticker and open its page
Insider activity, institutional flows, and fund ownership.
Insider trading analysis comparing the latest quarter against the stock's own historical baseline.
Very Bearish
Heavy insider selling in Q3 2026
17 sales totaling $25.7M (91.0K shares)
Share volume is 7x the historical average, extreme level
6 different insiders sold this quarter
Buying seen in 6 of 15 quarters
Selling pace
vs own 6-qtr average
Heavy
Stake sold
of active insiders' holdings
Seller breadth
vs 0.8 avg per quarter
Last insider purchase
buying in 6 of 16 quarters
Institutional ownership analysis with position momentum, 13F share flow, and ownership percentage trends.
Very Bullish
Institutions accumulating in Q2 2026
13F filings cover more than 100% of shares this quarter (overlapping reports), so ownership and share-flow figures are unreliable
Slight accumulation: 352 adding vs 271 reducing
Momentum improving from prior quarter
Net breadth
352 adding vs 271 reducing
Accumulating
Add / reduce ratio
in Q2 2026
New − closed
78 initiated, 68 exited
Top holders adding
largest holders that added
ETF and mutual fund activity breakdown showing buying vs selling funds, top fund holders, and detailed holdings.
Neutral
Mixed fund activity in Q2 2026
422 ETFs and mutual funds reporting
106 buying vs 88 selling (balanced)